Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

18.78
Delayed Data
As of Feb 16
 -0.25 / -1.31%
Today’s Change
12.05
Today|||52-Week Range
19.95
-2.39%
Year-to-Date
Abiomed's Extended FDA Nod for Impella Boosts Women Health
Feb 14 / Zacks.com - Paid Partner Content
Will Global Industrial Unit Aid Ecolab (ECL) in Q4 Earnings?
Feb 12 / Zacks.com - Paid Partner Content
CVS Health (CVS) Plans to Boost Hourly Minimum Wage Rate
Feb 13 / Zacks.com - Paid Partner Content
Henry Schein (HSIC) Q4 Earnings to Show Growth in All Lines?
Feb 12 / Zacks.com - Paid Partner Content
5 Reasons to Invest in PerkinElmer (PKI) Stock Right Now
Feb 13 / Zacks.com - Paid Partner Content
AmerisourceBergen (ABC) Gains on World Courier Unit Strength
Feb 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close19.03
Today’s open18.99
Day’s range18.70 - 19.16
Volume111,197
Average volume (3 months)200,933
Market cap$863.4M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-36.73%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+1.45%
P/E ratioNM
Price/Sales3.43
Price/Book2.64

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.45+0.74%
RVNCRevance Therapeutics...-0.55-1.73%
VNDAVanda Pharmaceutical...+0.20+1.18%
INSMInsmed Inc-1.14-4.49%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 13, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$255.2M
Annual profit (last year)$10.5M
Net profit margin4.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, COO &
Chief Scientist
Zi Ping Luo
CEO, Director &
Chief Science Officer
Yong Feng Zhang
Corporate headquarters
Rancho Cucamonga, California

Forecasts